drugs.com vs gcs-web.com
Market traction comparison · Updated Jul 2026
| drugs.com | gcs-web.com | Leads | |
|---|---|---|---|
| Monthly Visits | 18.9M | 600.1K | drugs.com |
| Bounce Rate | 58.5% | 51.1% | gcs-web.com |
| SEO & Keywords | 30 | 30 | Tie |
| Domain Age | 27y 8m | 10y 1m | drugs.com |
drugs.com leads in 2 of 4 dimensions, while gcs-web.com leads in 1.
Growth Momentum
| drugs.com | gcs-web.com | Leads | |
|---|---|---|---|
| Monthly Visits | 18.9M | 600.1K | drugs.com |
| MoM Change | +11% | +0% | drugs.com |
| Avg. Session | 1m56s | 1m04s | drugs.com |
| Pages / Visit | 2.4 | 2.0 | drugs.com |
Growth Momentum · Insight
drugs.com receives 31.4x more monthly traffic than gcs-web.com (18.9M vs 600.1K).
Acquisition Strategy
| drugs.com | gcs-web.com | Leads | |
|---|---|---|---|
| Primary Channel | Search 69% | Search 40% | |
| Bounce Rate | 58.5% | 51.1% | gcs-web.com |
| SEO & Keywords | 30 | 30 | — |
Keyword Overlap Rate: 20%
Acquisition Strategy · Insight
drugs.com acquires users primarily through Search (69%), while gcs-web.com relies on Search (40%). This reflects fundamentally different go-to-market strategies — gcs-web.com's higher direct traffic suggests stronger brand recognition or product-led growth, while drugs.com's search reliance means growth is more scalable but more vulnerable to algorithm changes.
Business Maturity
| drugs.com | gcs-web.com | Leads | |
|---|---|---|---|
| Domain Age | 27y 8m | 10y 1m | drugs.com |
| Registered | Dec 1998 | Jul 2016 | |
| Expires | Dec 2026 | Jul 2026 |
Business Maturity · Insight
drugs.com has been in the market for over a decade, indicating established presence.
Market Position
| drugs.com | gcs-web.com | Leads | |
|---|---|---|---|
| Global Rank | #3.4K | #96.6K | drugs.com |
| Category Rank | #3 | #357 | drugs.com |
drugs.com only
gcs-web.com only
Market Position · Insight
Each has untapped markets the other serves: drugs.com could expand into Australia, while gcs-web.com could target Colombia.
Key Takeaways
- •drugs.com receives 31.4x more monthly traffic than gcs-web.com (18.9M vs 600.1K).
- •drugs.com acquires users primarily through Search (69%), while gcs-web.com relies on Search (40%). This reflects fundamentally different go-to-market strategies — gcs-web.com's higher direct traffic suggests stronger brand recognition or product-led growth, while drugs.com's search reliance means growth is more scalable but more vulnerable to algorithm changes.
- •drugs.com receives 31.4x more monthly traffic than gcs-web.com (18.9M vs 600.1K).
- •drugs.com keeps visitors significantly longer (1m56s avg session vs gcs-web.com's 1m04s), suggesting deeper product engagement or stickier content.
- •They share 10 keywords (20% overlap), indicating direct search competition.
- •drugs.com has a 18-year head start in the market.
You've seen the gap. Now steal the playbook.
A Growth Teardown reverse-engineers exactly how each product grows — traffic sources, backlink strategy, keyword gaps, and scored action items you can copy this week.
Related Comparisons
Report based on data from July 2026